Breast cancer risk AI startup bypasses doctors, markets directly to patients

A startup is marketing its AI-based breast cancer risk prediction tool directly to consumers, circumventing traditional gatekeepers like doctors and insurers. This marks a shift in healthcare AI commercialization, raising questions about regulatory oversight and clinical validation. The move could accelerate patient adoption but also introduces risks of unregulated medical advice.